Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024
Cash flows from operating activities:
Net loss	$ (7,408,269)	$ (4,208,702)
Adjustments to reconcile net loss to net cash from operating activities:
Net unrealized loss on equity securities at fair value	2,553	729,793
Net loss from equity method investments at fair value	140,694	1,537,455
Net realized gain on investments	(151,370)	0
Impairment loss	4,406,249	0
Straight-line rent	0	(16,270)
Depreciation and amortization	2,280,756	1,559,668
Amortization of deferred financing costs and debt mark-to-market	301,588	248,437
Accretion of above (below) market lease, net	(67,324)	(95,434)
Changes in assets and liabilities:
Investments income, rents and other receivables	(319,497)	327,940
Prepaid expenses and other assets	101,663	12,522
Deferred rent and other liabilities	58,063	(19,896)
Accounts payable and accrued liabilities	1,313,789	441,883
Due to related entities	(14,536)	(330)
Net cash from operating activities	644,359	517,066
Cash flows from investing activities:
Proceeds from sale of investments	670,727	0
Investments in real estate assets	(5,826,304)	(5,055,288)
Purchase of investments	(171,064)	(393,530)
Return of capital distributions	0	21,000
Net cash from investing activities	(5,326,641)	(5,427,818)
Cash flows from financing activities:
Proceeds from mortgage notes payable	5,889,891	2,945,715
Payments on mortgage notes payable	(403,206)	(294,927)
Payments on notes payable	(4,860)	(4,676)
Dividend to common stockholders	(1,662,824)	(1,345,908)
Payment on finance lease liabilities	(56,021)	(14,216)	$ (104,416)
Payment of selling commissions and fees	(169,793)	(184,766)
Contributions by non-controlling interest holders	359,999	0
Distributions to non-controlling interests holders	(342,071)	(167,365)
Redemption of common stock, net of stock redemption payable	0	(444,999)
Capital pending acceptance	(200,300)	(396,600)
Net cash from financing activities	3,572,898	1,451,608
Net decrease in cash, cash equivalents and restricted cash	(1,109,384)	(3,459,144)
Cash, cash equivalents and restricted cash at beginning of the period	13,077,339	18,141,019	18,141,019
Cash, cash equivalents and restricted cash at end of the period	11,967,955	14,681,875	13,077,339
Cash and cash equivalents at end of the period	10,693,380	13,981,263	11,777,930
Restricted cash at end of the period	778,923	71,793	$ 778,330
Cash and restricted cash at end of the period classified as assets held for sale	495,652	628,819
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance Operating Partnership Preferred Units through reinvestment of dividends	23,514	20,454
Cash paid for interest	1,611,521	1,015,556
Stock-based compensation	465,500	0
Operating Partnership Class A conversion to common stock	859	0
Capitalized construction in progress outstanding as accounts payable	670,977	0
Issuance of common stock through reinvestment of dividends	0	443,271
Green Valley Medical Center, LP [Member]
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance of the Operating Partnership Preferred Units for the purchase of interest (Note 1)	2,712,194	0
Fair value of assets acquired from consolidation	13,621,753	0
Fair value of liabilities assumed from consolidation	8,904,457	0
Series A Preferred Stock [Member]
Cash flows from financing activities:
Dividend to preferred stockholders	(238,403)	0
Proceeds from issuance of preferred stock	50,000	1,359,350
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance of preferred stock through reinvestment of dividends	46,333	39,858
Issuance Operating Partnership Preferred Units through reinvestment of dividends	23,514	20,454
Series B Preferred Stock [Member]
Cash flows from financing activities:
Dividend to preferred stockholders	(6,013)	0
Proceeds from issuance of preferred stock	356,499	0
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance of preferred stock through reinvestment of dividends	1,912	0
Increase in liquidation preference	34,037	0
Increase in liquidation preference of Operating Partnership Preferred Units	$ 24,307	$ 0